Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Suzhou Ciclo Pharmaceutical is a core manufacturing subsidiary of BrightGene Bio-Medical Technology, located in the Suzhou Industrial Park, China. The company specializes in the development and large-scale production of high-barrier generic drugs and complex pharmaceutical formulations. Its state-of-the-art facilities are designed to comply with global GMP standards, including those of the FDA and EMA, facilitating international market access. Suzhou Ciclo supports a diverse portfolio of products across therapeutic areas such as oncology, anti-infectives, and metabolic diseases. As a key component of BrightGene's vertically integrated business model, the company bridges the gap between advanced API synthesis and finished dosage form manufacturing. Through its focus on technical innovation and quality, Suzhou Ciclo aims to provide high-quality, cost-effective therapeutic solutions to patients worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 苏州西克罗制药.